NewLink Genetics Corp (NASDAQ:NLNK)

42.89
Delayed Data
As of May 28
 -0.47 / -1.08%
Today’s Change
17.32
Today|||52-Week Range
58.73
+7.90%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close43.36
Today’s open43.20
Day’s range41.76 - 43.26
Volume269,474
Average volume (3 months)702,183
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-151.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio11.2
Price/Sales6.41
Price/Book5.95

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...+0.10+1.07%
EBSEmergent BioSolution...+0.73+2.35%
FOLDAmicus Therapeutics ...+0.23+1.92%
RGENRepligen Corp+0.36+0.89%
Data as of 4:03pm ET, 05/28/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers